Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1987 Oct;99(2):445–453. doi: 10.1017/s0950268800067947

Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

C DiGiovanni 1, T V Riley 1, G F Hoyne 1, R Yeo 1, P Cooksey 1
PMCID: PMC2249296  PMID: 3119360

Abstract

During a 3-year period Branhamella catarrhalis was isolated in significant numbers from 239 (1.3%) of 19,488 specimens of sputum sent for routine microbiological examination at a 700-bed general hospital. The majority of patients (83%) were over 60 years of age and 65% were male. There was a distinct seasonal variation in isolations with a peak incidence during the winter and early spring, a pattern not found with other pathogens. Susceptibility to amoxycillin decreased by approximately 50% over the 3 years, corresponding to an increased incidence of beta-lactamase-producing strains. There were minimal changes in susceptibility to other antimicrobial agents. Underlying pulmonary disease was the major factor predisposing to B. catarrhalis infection, and 71% of patients were smokers or ex-smokers.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Croughan M. J., Calder M. A. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrob Agents Chemother. 1984 Sep;26(3):424–425. doi: 10.1128/aac.26.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Corkill J. E., Makin T. A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract: with particular reference to Branhamella catarrhalis. Med Lab Sci. 1982 Jan;39(1):3–10. [PubMed] [Google Scholar]
  3. Doern G. V., Morse S. A. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980 Feb;11(2):193–195. doi: 10.1128/jcm.11.2.193-195.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. EDWARDS J. H. The recognition and estimation of cyclic trends. Ann Hum Genet. 1961 May;25:83–87. doi: 10.1111/j.1469-1809.1961.tb01501.x. [DOI] [PubMed] [Google Scholar]
  6. Kamme C., Eliasson I., Knutson B. K., Vang M. Plasmid-mediated beta-lactamase in Branhamella catarrhalis. Drugs. 1986;31 (Suppl 3):55–63. doi: 10.2165/00003495-198600313-00013. [DOI] [PubMed] [Google Scholar]
  7. McLeod D. T., Ahmad F., Capewell S., Croughan M. J., Calder M. A., Seaton A. Increase in bronchopulmonary infection due to branhamella catarrhalis. Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1103–1105. doi: 10.1136/bmj.292.6528.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McLeod D. T., Ahmad F., Power J. T., Calder M. A., Seaton A. Bronchopulmonary infection due to Branhamella catarrhalis. Br Med J (Clin Res Ed) 1983 Nov 12;287(6403):1446–1447. doi: 10.1136/bmj.287.6403.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Murray P. R., Washington J. A. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc. 1975 Jun;50(6):339–344. [PubMed] [Google Scholar]
  10. Ninane G., Joly J., Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J. 1978 Feb 4;1(6108):276–278. doi: 10.1136/bmj.1.6108.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schalén L., Christensen P., Kamme C., Miörner H., Pettersson K. I., Schalén C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis. 1980;12(4):277–280. doi: 10.3109/inf.1980.12.issue-4.07. [DOI] [PubMed] [Google Scholar]
  12. Slevin N. J., Aitken J., Thornley P. E. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet. 1984 Apr 7;1(8380):782–783. doi: 10.1016/s0140-6736(84)91288-1. [DOI] [PubMed] [Google Scholar]
  13. Smith J. M., Lockwood B. M. A 2-year survey of Branhamella catarrhalis in a general hospital. J Hosp Infect. 1986 May;7(3):277–282. doi: 10.1016/0195-6701(86)90078-2. [DOI] [PubMed] [Google Scholar]
  14. Wilson M. J., Martin D. E. Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory. J Clin Pathol. 1972 Aug;25(8):697–700. doi: 10.1136/jcp.25.8.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. von Graevenitz A., Rathbone R. R. Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases. South Med J. 1981 Sep;74(9):1095–1096. doi: 10.1097/00007611-198109000-00021. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES